{"DataElement":{"publicId":"2006171","version":"1","preferredName":"Protocol New Approaches to Brain Tumor Therapy Consortium Identifier Number","preferredDefinition":"the Cooperative Group-specific alphanumeric identifier assigned to an NCI-sponsored protocol by the NABTT Brain Tumor Consortium (NABTT).","longName":"PROT_NABTT_ID_NUM","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195038","version":"1","preferredName":"Protocol New Approaches to Brain Tumor Therapy Consortium Identifier","preferredDefinition":"information related to the protocol's NABTT ID.","longName":"PROT_NABTT_ID","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2176994","version":"1","preferredName":"Protocol","preferredDefinition":"An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.","longName":"Protocol","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AC7-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2660782","version":"1","preferredName":"New Approaches to Brain Tumor Therapy Consortium Identifier","preferredDefinition":"The primary objective of the \"New Approaches to Brain Tumor Therapy (NABTT)\" CNS Consortium is to improve the therapeutic outcome for adults with primary brain tumors. It is funded by the National Cancer Institute to conduct Phase I and II clinical evaluations of promising new treatment strategies (surgery, radiation, chemotherapy, and biologic therapies), routes of administration, and clinical trial design in the treatment of primary malignancies of the central nervous system. The secondary objective of the NABTT CNS Consortium is to share human brain tumor specimens and clinical and laboratory data to conduct additional research pertaining to 1) the basic biology of primary brain tumors, 2) the neuro-pharmacology of new therapies for primary brain tumors, and 3) improving the care and quality of life of adults with primary brain tumors. (http://www.nabtt.org:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"CL322389:C25364","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New Approaches to Brain Tumor Therapy Consortium","conceptCode":"CL322389","definition":"The primary objective of the \"New Approaches to Brain Tumor Therapy (NABTT)\" CNS Consortium is to improve the therapeutic outcome for adults with primary brain tumors. It is funded by the National Cancer Institute to conduct Phase I and II clinical evaluations of promising new treatment strategies (surgery, radiation, chemotherapy, and biologic therapies), routes of administration, and clinical trial design in the treatment of primary malignancies of the central nervous system. The secondary objective of the NABTT CNS Consortium is to share human brain tumor specimens and clinical and laboratory data to conduct additional research pertaining to 1) the basic biology of primary brain tumors, 2) the neuro-pharmacology of new therapies for primary brain tumors, and 3) improving the care and quality of life of adults with primary brain tumors. (http://www.nabtt.org","evsSource":"NCI_META_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identifier","conceptCode":"C25364","definition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E73C82-D198-5882-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EBC19B2D-D97F-603E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018389","version":"1","preferredName":"Protocol Identifier Number","preferredDefinition":"the numeric or alphanumeric identification assigned to the study by the National Cancer Institute.","longName":"PROT_ID_NUM","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008529","version":"1","preferredName":"Research Protocols","preferredDefinition":"the identification of cancer research protocols.","longName":"RSCH_PROT","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECC2BE-2F27-348A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184315","version":"1","preferredName":"Number","preferredDefinition":"Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"Number","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1E43-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3A8191F-BCD8-233F-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"CAMPBELB","dateModified":"2007-03-19","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Alternate Question Text","description":"NABTT Protocol Number","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Preferred Question Text","description":"NABTT Study No.","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B3D32047-0C6D-190C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-09","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-09","modifiedBy":"CAMPBELB","dateModified":"2005-01-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}